Prophylaxis for neonatal group B streptococcus infections

J. D. Siegel

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

For the past two decades, group B streptococcus (GBS) has been the pathogen most frequently isolated from neonates with invasive bacterial disease. This is a review of the relevant aspects of microbiology, epidemiology, and clinical manifestations and a summary of the major studies of prevention strategies that led to the development of the 1996 consensus guidelines for prevention of perinatal GBS disease. There is now sufficient experience to know that ≤80% of cases of early onset GBS disease can be prevented when a protocol for intrapartum chemoprophylaxis with either penicillin or ampicillin is implemented consistently within a delivery population. Present controversies revolve around the choice between a universal screening-based strategy versus a risk factor-based strategy, optimal management of the neonate born to a mother who received intrapartum antimicrobial prophylaxis, and effective methods to ensure implementation. The present guidelines will likely be refined as additional experience is gained.

Original languageEnglish (US)
Pages (from-to)33-49
Number of pages17
JournalSeminars in Perinatology
Volume22
Issue number1
DOIs
StatePublished - 1998

Fingerprint

Streptococcus agalactiae
Infection
Newborn Infant
Guidelines
Chemoprevention
Ampicillin
Microbiology
Penicillins
Consensus
Epidemiology
Mothers
Population

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Prophylaxis for neonatal group B streptococcus infections. / Siegel, J. D.

In: Seminars in Perinatology, Vol. 22, No. 1, 1998, p. 33-49.

Research output: Contribution to journalArticle

Siegel, J. D. / Prophylaxis for neonatal group B streptococcus infections. In: Seminars in Perinatology. 1998 ; Vol. 22, No. 1. pp. 33-49.
@article{2dc5d1c17e124fc7b98549ec7d4968e9,
title = "Prophylaxis for neonatal group B streptococcus infections",
abstract = "For the past two decades, group B streptococcus (GBS) has been the pathogen most frequently isolated from neonates with invasive bacterial disease. This is a review of the relevant aspects of microbiology, epidemiology, and clinical manifestations and a summary of the major studies of prevention strategies that led to the development of the 1996 consensus guidelines for prevention of perinatal GBS disease. There is now sufficient experience to know that ≤80{\%} of cases of early onset GBS disease can be prevented when a protocol for intrapartum chemoprophylaxis with either penicillin or ampicillin is implemented consistently within a delivery population. Present controversies revolve around the choice between a universal screening-based strategy versus a risk factor-based strategy, optimal management of the neonate born to a mother who received intrapartum antimicrobial prophylaxis, and effective methods to ensure implementation. The present guidelines will likely be refined as additional experience is gained.",
author = "Siegel, {J. D.}",
year = "1998",
doi = "10.1016/S0146-0005(98)80006-2",
language = "English (US)",
volume = "22",
pages = "33--49",
journal = "Seminars in Perinatology",
issn = "0146-0005",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Prophylaxis for neonatal group B streptococcus infections

AU - Siegel, J. D.

PY - 1998

Y1 - 1998

N2 - For the past two decades, group B streptococcus (GBS) has been the pathogen most frequently isolated from neonates with invasive bacterial disease. This is a review of the relevant aspects of microbiology, epidemiology, and clinical manifestations and a summary of the major studies of prevention strategies that led to the development of the 1996 consensus guidelines for prevention of perinatal GBS disease. There is now sufficient experience to know that ≤80% of cases of early onset GBS disease can be prevented when a protocol for intrapartum chemoprophylaxis with either penicillin or ampicillin is implemented consistently within a delivery population. Present controversies revolve around the choice between a universal screening-based strategy versus a risk factor-based strategy, optimal management of the neonate born to a mother who received intrapartum antimicrobial prophylaxis, and effective methods to ensure implementation. The present guidelines will likely be refined as additional experience is gained.

AB - For the past two decades, group B streptococcus (GBS) has been the pathogen most frequently isolated from neonates with invasive bacterial disease. This is a review of the relevant aspects of microbiology, epidemiology, and clinical manifestations and a summary of the major studies of prevention strategies that led to the development of the 1996 consensus guidelines for prevention of perinatal GBS disease. There is now sufficient experience to know that ≤80% of cases of early onset GBS disease can be prevented when a protocol for intrapartum chemoprophylaxis with either penicillin or ampicillin is implemented consistently within a delivery population. Present controversies revolve around the choice between a universal screening-based strategy versus a risk factor-based strategy, optimal management of the neonate born to a mother who received intrapartum antimicrobial prophylaxis, and effective methods to ensure implementation. The present guidelines will likely be refined as additional experience is gained.

UR - http://www.scopus.com/inward/record.url?scp=0031965982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031965982&partnerID=8YFLogxK

U2 - 10.1016/S0146-0005(98)80006-2

DO - 10.1016/S0146-0005(98)80006-2

M3 - Article

C2 - 9523398

AN - SCOPUS:0031965982

VL - 22

SP - 33

EP - 49

JO - Seminars in Perinatology

JF - Seminars in Perinatology

SN - 0146-0005

IS - 1

ER -